Jonathan Wygant Appointed Chief Accounting Officer at Veracyte

Jonathan Wygant will report to Rebecca Chambers, Veracyte’s chief financial officer.

Jonathan Wygant will oversee all aspects of the company’s global accounting operations, financial reporting, and tax functions.

“We are thrilled to welcome Jonathan to Veracyte,” said Ms. Chambers. “He brings a depth of expertise and experience leading accounting operations for a range of healthcare companies, including global organizations. As we advance our global strategic vision, his accounting leadership will be critical to ensuring our organization’s continued success.”

Mr. Wygant most recently served as corporate controller at Biosplice Therapeutics, Inc. (formerly Samumed, LLC), a clinical-stage biotechnology company. In this role, he led all finance, accounting and reporting functions within the company.

Prior to that, Mr. Wygant was the chief financial officer at Cibus Global, LLC, where he oversaw the company’s financial operations. He also served as vice president, controller and chief accounting officer at Alere, Inc., a point-of-care diagnostics company which was acquired by Abbott in 2016.

Prior to that, Mr. Wygant held various leadership roles at CareFusion, including senior vice president, controller and chief accounting officer.

 

Other Executives In the News

SourceVeracyte
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr A Burton Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
John Taylor brings more than 30 years of regulatory experience to his role at ELIQUENT, including a distinguished 20-year career at the U.S. Food and Drug Administration (FDA), where he served in multiple leadership positions, including as FDA’s Acting Deputy Principal Commissioner, FDA Counselor to the Commissioner, Acting Deputy Commissioner for Global Regulatory Operations and Policy, and Associate Commissioner for Regulatory Affairs.
Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version